1-8 of 8
Andrew Kin, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Pre-Transplant Induction Therapy on Outcomes of Patients Who Undergo Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in First Complete Remission

Omar Albanyan, MD, Samer Alkassis, Seongho Kim, PhD, Andrew Kin, MD, Asif Alavi, MD, Lois Ayash, MD, Voravit Ratanatharathorn, MD, Dipenkumar Modi, MD, Joseph P. Uberti, MD, PhD, Abhinav Deol, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
https://doi.org/10.1182/blood-2020-140079
Published: 2020
Journal Articles

A Phase II Study of Daratumumab in Patients with High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma: First Report of Efficacy and Safety

Omar Nadeem, MD, Robert Redd, Laura V. Stampleman, Jeffrey V. Matous, MD, Andrew J. Yee, MD, Jeffrey A. Zonder, Andrew Kin, MD, Jacalyn Rosenblatt, MD, Mark Bustoros, MD, Julia Prescott, MSN,NP, Alexandra Savell, BS, Kathleen Guimond, RN, Erin Frey, RN, Rachel Styles, BS, Adrienne Bielawski, Cody J Boehner, BS, Nang Kham Su, BA, Multiple Myeloma Research Foundation Multiple Myeloma Research Foundation, The Leukemia & Lymphoma Society The Leukemia & Lymphoma Society, BCRP Blood Cancer Research Partnership, Adam S Sperling, MD PhD, Giada Bianchi, MD, Jacob P. Laubach, MD, Jorge J. Castillo, MD, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD, Paul G. Richardson, MD, Lorenzo Trippa, Irene M. Ghobrial, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1898.
https://doi.org/10.1182/blood-2019-129103
Published: 2019
Journal Articles

Use of Thymoglobulin with Lower Dose of Busulfan Results in Less Acute Gvhd Following Unrelated Donor Allogeneic Stem Cell Transplantation for AML without Affecting Relapse-Free and Overall Survival

Dipenkumar Modi, MD, Vijendra Singh, MD, Seongho Kim, PhD, Abhinav Deol, MD, Asif Alavi, MD, Lois Ayash, MD, Andrew Kin, MD, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4488.
https://doi.org/10.1182/blood-2019-125418
Published: 2019
Journal Articles

Absolute Lymphocyte Count (ALC) Less Than 100 Predicts Adverse Transplant Outcomes with Rabbit Thymoglobulin in Patients Undergoing Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation

Dipenkumar Modi, MD, Malini Surapaneni, MD, Seongho Kim, PhD, Lois Ayash, MD, Asif Alavi, MD, Andrew Kin, MD, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD, Abhinav Deol, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4527.
https://doi.org/10.1182/blood-2019-125437
Published: 2019
Journal Articles

Can Peri-Transplant Radiation Therapy Improve Outcomes of Autologous Stem Cell Transplant in Hodgkin Lymphoma?

Harsh Shah, DO, Paramveer Singh, MD, Jorgena Kosti, DO, Hyejeong Jang, Seongho Kim, PhD, Andrew Kin, MD, Asif Alavi, MD, Lois Ayash, MD, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD, Abhinav Deol, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5702.
https://doi.org/10.1182/blood-2019-124931
Published: 2019
Journal Articles

A Phase 2 Study with Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma with Upfront Daratumumab-Based Therapy

J Christine Ye, MDMSc, Philip S Boonstra, PhD, Daniel F. Boyer, MD PhD, Larry D. Anderson, MD PhD, Brea C. Lipe, MD, Andrew Kin, MD, Erica L. Campagnaro, MD, Matthew J. Pianko, MD, Moshe Talpaz, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3191.
https://doi.org/10.1182/blood-2019-132204
Published: 2019
Journal Articles

Maintenance Therapy after Second Autologous Stem Cell Transplant in Multiple Myeloma Improves Overall Survival

Dipenkumar Modi, MD, Seongho Kim, PhD, Jie Chi, MD, Lois Ayash, MD, Asif Alavi, MD, Andrew Kin, MD, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD, Abhinav Deol, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3311.
https://doi.org/10.1182/blood-2019-124838
Published: 2019
Journal Articles

Scheduled Outpatient Red Blood Cell Exchange Program Reduces Admission and Complications in Sickle Cell Disease

Naresh Bumma, MD, Andrew Kin, MD, Malini Surapaneni, MD, Seongho Kim, PhD, Paul Swerdlow, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3536.
https://doi.org/10.1182/blood.V130.Suppl_1.3536.3536
Published: 2017